Engineered Proteins for Targeted Full Spectrum Influenza Neutralization
Exclusively Licensed
Invention type: Technology
/
Case number: #13937
The present invention provides novel agents for broad spectrum influenza neutralization. The present invention provides agents for inhibiting influenza infection by bind to the influenza virus and/or hemagglutinin (HA) polypeptides and/or HA receptors, and reagents and methods relating thereto. The present invention provides a system for analyzing interactions between infolds and the interaction partners that bind to them.
Researchers
Ram Sasisekharan
/
Vidya Subramanian
/
Venkataramanan Soundararajan
/
Karthik Viswanathan
/
Sasisekharan Raguram
/
Viswanathan Sasisekharan
Departments: School of Engineering
Technology Areas: Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living
-
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Published application -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 8,637,456 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
European Patent Convention | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Granted | 6,210,685 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Canada | Granted | 2,787,940 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Australia | Granted | 2,011,210,840 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 9,334,309 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Japan | Published application -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United States of America | Granted | 9,572,861 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Germany | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Spain | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
France | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
United Kingdom | Granted | 2,528,615 -
engineered polypeptide agents for targeted broad spectrum influenza neutralization
Italy | Granted | 2,528,615
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.